Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 13,654 | 12,852 | 7,899 | 10,313 | 12,318 |
| Cost of Goods | 10,400 | 9,722 | 6,574 | 8,245 | 9,325 |
| Gross Profit | 3,254 | 3,130 | 1,325 | 2,068 | 2,993 |
| Operating Expenses | 4,422 | 4,112 | 3,327 | 2,661 | 2,905 |
| Operating Income | -768 | -260 | -1,428 | -348 | 413 |
| Interest Expense | 594 | 440 | 300 | 335 | 374 |
| Other Income | -652 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -2,014 | -700 | -1,728 | -683 | 39 |
| Income Tax | N/A | N/A | N/A | 432 | -5 |
| Net Income Continuous | -2,014 | -700 | -1,728 | -1,115 | 44 |
| Net Income | $-2,014 | $-700 | $-1,728 | $-1,103 | $34 |
| EPS Basic Total Ops | -0.35 | -0.13 | -0.47 | -7.20 | -6.33 |
| EPS Basic Continuous Ops | -0.35 | -0.13 | -0.33 | -7.07 | 0.28 |
| EPS Diluted Total Ops | -0.35 | -0.13 | -0.47 | -7.20 | -6.33 |
| EPS Diluted Continuous Ops | -0.35 | -0.13 | -0.33 | -7.07 | 0.28 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.13 | -0.47 | N/A | N/A |
| EBITDA(a) | $-399 | $-146 | $-1,312 | $-197 | $537 |